Subscriptions significantly exceed targeted raising amount Not for distribution to United States news wire services or dissemination in the U.S.

The U.S. Court of Appeals for the First Circuit recently provided important clarity—and welcome relief—for clinical laboratories facing False Claims Act (“FCA”) allegations based on a lack of medical ...